247 results on '"Turner, Hannah L."'
Search Results
2. HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodies
3. Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways
4. Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
5. Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site
6. Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes
7. Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
8. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
9. Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics
10. Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates
11. Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin
12. Anti-influenza H7 human antibody targets antigenic site in hemagglutinin head domain interface
13. Engineered immunogen binding to alum adjuvant enhances humoral immunity
14. Protocol for analyzing antibody responses to glycoprotein antigens using electron-microscopy-based polyclonal epitope mapping
15. Glycosylation of Human IgA Directly Inhibits Influenza A and Other Sialic-Acid-Binding Viruses
16. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
17. Myosin-driven transport network in plants
18. Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface
19. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak
20. Morphology and Syntax in Late Talkers at Age 5
21. Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer
22. Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct omicron SARS-CoV-2 subvariants
23. Author Correction: A Engineered immunogen binding to alum adjuvant enhances humoral immunity
24. Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins.
25. Pre-fusion structure of a human coronavirus spike protein
26. Morphology and syntax in late talkers at age 5
27. Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape
28. Human antibody recognition of H7N9 influenza virus HA following natural infection
29. EBOLA VIRUS: Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak
30. Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
31. Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins
32. Prominent Neutralizing Antibody Response Targeting the Ebolavirus Glycoprotein Subunit Interface Elicited by Immunization
33. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
34. Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface
35. Polyclonal epitope mapping reveals temporal dynamics and diversity of human antibody responses to H5N1 vaccination
36. HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite
37. A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody
38. Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
39. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
40. Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins
41. Drivers of recombinant soluble influenza A virus hemagglutinin and neuraminidase expression in mammalian cells
42. Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens
43. Polyclonal epitope cartography reveals the temporal dynamics and diversity of human antibody responses to H5N1 vaccination
44. Structural and functional analysis of cooperativity in a potent human antibody cocktail against Ebola virus
45. Heterosubtypic human antibody response to influenza H7N9 in survivors of natural infection
46. Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits
47. Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines
48. Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
49. Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies
50. Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.